Sensex, Nifty end flat for 3rd session; heavyweights offset pharma losses; broader market rise up to 2%
Gains in heavyweight financials offset losses in pharma stocks, which fell after U.S. President Donald Trump’s tariff threats. While the pharma tariffs could impact sentiment in the short to medium term, analysts believe the effect may not be long-lasting. Sensex and Nifty ended flat for the third session in a row ahead of the FOMC meeting…